Thaddeus Allen
Professional who facilitates science, strategy and team building in biotech with a knack for deconstructing complexity to provide insight and direction.
Research Expertise
About
Publications
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Cell Metabolism / Feb 01, 2012
Yuneva, M. O., Fan, T. W. M., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Matés, J. M., Alonso, F. J., Wang, C., Seo, Y., Chen, X., & Bishop, J. M. (2012). The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type. Cell Metabolism, 15(2), 157–170. https://doi.org/10.1016/j.cmet.2011.12.015
Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response
Proceedings of the National Academy of Sciences / Apr 08, 2008
Swarbrick, A., Roy, E., Allen, T., & Bishop, J. M. (2008). Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response. Proceedings of the National Academy of Sciences, 105(14), 5402–5407. https://doi.org/10.1073/pnas.0801505105
Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma
Cancer Research / Sep 13, 2011
Allen, T. D., Rodriguez, E. M., Jones, K. D., & Bishop, J. M. (2011). Activated Notch1 Induces Lung Adenomas in Mice and Cooperates with Myc in the Generation of Lung Adenocarcinoma. Cancer Research, 71(18), 6010–6018. https://doi.org/10.1158/0008-5472.can-11-0595
Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma
Oncotarget / May 13, 2014
Capaccione, K. M., Hong, X., Morgan, K. M., Liu, W., Bishop, M. J., Liu, L., Markert, E., Deen, M., Minerowicz, C., Bertino, J. R., Allen, T., & Pine, S. R. (2014). Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma. Oncotarget, 5(11), 3636–3650. https://doi.org/10.18632/oncotarget.1970
Grg1 Acts as a Lung-Specific Oncogene in a Transgenic Mouse Model
Cancer Research / Feb 01, 2006
Allen, T., van Tuyl, M., Iyengar, P., Jothy, S., Post, M., Tsao, M.-S., & Lobe, C. G. (2006). Grg1 Acts as a Lung-Specific Oncogene in a Transgenic Mouse Model. Cancer Research, 66(3), 1294–1301. https://doi.org/10.1158/0008-5472.can-05-1634
Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis
Cancer Biology & Therapy / Nov 02, 2014
Dong, F., Zhou, X., Li, C., Yan, S., Deng, X., Cao, Z., Li, L., Tang, B., Allen, T. D., & Liu, J. (2014). Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis. Cancer Biology & Therapy, 15(11), 1479–1488. https://doi.org/10.4161/15384047.2014.955728
Notch and Wingless Regulate Expression of Cuticle Patterning Genes
Molecular and Cellular Biology / Aug 01, 1999
Wesley, C. S. (1999). Notch and Wingless Regulate Expression of Cuticle Patterning Genes. Molecular and Cellular Biology, 19(8), 5743–5758. https://doi.org/10.1128/mcb.19.8.5743
Interaction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer
Cancer Research / Mar 14, 2011
Allen, T. D., Zhu, C. Q., Jones, K. D., Yanagawa, N., Tsao, M.-S., & Bishop, J. M. (2011). Interaction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer. Cancer Research, 71(6), 2212–2221. https://doi.org/10.1158/0008-5472.can-10-3590
Cadmium induces vascular permeability via activation of the p38 MAPK pathway
Biochemical and Biophysical Research Communications / Jul 01, 2014
Dong, F., Guo, F., Li, L., Guo, L., Hou, Y., Hao, E., Yan, S., Allen, T. D., & Liu, J. (2014). Cadmium induces vascular permeability via activation of the p38 MAPK pathway. Biochemical and Biophysical Research Communications, 450(1), 447–452. https://doi.org/10.1016/j.bbrc.2014.05.140
TALE Homeoproteins as HOX11-Interacting Partners in T-cell Leukemia
Leukemia & Lymphoma / Jan 01, 2000
Allen, T. D., Zhlp, Y.-X., Hawley, T. S., & Hawley, R. G. (2000). TALE Homeoproteins as HOX11-Interacting Partners in T-cell Leukemia. Leukemia & Lymphoma, 39(3–4), 241–256. https://doi.org/10.3109/10428190009065824
Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice
Biochemical and Biophysical Research Communications / Aug 01, 2015
Liu, J., Li, Y., Dong, F., Li, L., Masuda, T., Allen, T. D., & Lobe, C. G. (2015). Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice. Biochemical and Biophysical Research Communications, 463(4), 1230–1236. https://doi.org/10.1016/j.bbrc.2015.06.090
Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
British Journal of Cancer / May 22, 2019
Sellers, K., Allen, T. D., Bousamra, M., Tan, J., Méndez-Lucas, A., Lin, W., Bah, N., Chernyavskaya, Y., MacRae, J. I., Higashi, R. M., Lane, A. N., Fan, T. W.-M., & Yuneva, M. O. (2019). Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes. British Journal of Cancer, 121(1), 51–64. https://doi.org/10.1038/s41416-019-0464-z
Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway
Experimental and Therapeutic Medicine / Sep 30, 2014
GUO, L., DONG, F., HOU, Y., CAI, W., ZHOU, X., HUANG, A.-L., YANG, M., ALLEN, T. D., & LIU, J. (2014). Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway. Experimental and Therapeutic Medicine, 8(6), 1707–1712. https://doi.org/10.3892/etm.2014.1997
GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature
Oncotarget / Nov 30, 2017
Xu, Y., Pan, S., Liu, J., Dong, F., Cheng, Z., Zhang, J., Qi, R., Zang, Q., Zhang, C., Wang, X., Zhang, J., Wang, F., Allen, T. D., & Liu, J. (2017). GATA3-induced vWF upregulation in the lung adenocarcinoma vasculature. Oncotarget, 8(66), 110517–110529. https://doi.org/10.18632/oncotarget.22806
Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction
Experimental and Therapeutic Medicine / Sep 01, 2015
LI, Y., LI, L., DONG, F., GUO, L., HOU, Y., HU, H., YAN, S., ZHOU, X., LIAO, L., ALLEN, T. D., & LIU, J. (2015). Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction. Experimental and Therapeutic Medicine, 10(5), 1743–1749. https://doi.org/10.3892/etm.2015.2721
The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin 1/Atg6-mediated lethal autophagy in polyploid cells
Experimental Cell Research / Sep 01, 2020
Zhang, J., Zhang, S., Shi, Q., Allen, T. D., You, F., & Yang, D. (2020). The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin 1/Atg6-mediated lethal autophagy in polyploid cells. Experimental Cell Research, 394(1), 112112. https://doi.org/10.1016/j.yexcr.2020.112112
Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression
Biomedicine & Pharmacotherapy / Mar 01, 2018
Cheng, Z., Qi, R., Li, L., Liu, Q., Zhang, W., Zhou, X., Xu, D., Allen, T. D., Pan, S., & Liu, J. (2018). Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression. Biomedicine & Pharmacotherapy, 99, 313–318. https://doi.org/10.1016/j.biopha.2018.01.078
Aberrant Activation of Notch1 Signaling in Glomerular Endothelium Induces Albuminuria
Circulation Research / Mar 05, 2021
Li, L., Liu, Q., Shang, T., Song, W., Xu, D., Allen, T. D., Wang, X., Jeong, J., Lobe, C. G., & Liu, J. (2021). Aberrant Activation of Notch1 Signaling in Glomerular Endothelium Induces Albuminuria. Circulation Research, 128(5), 602–618. https://doi.org/10.1161/circresaha.120.316970
Pro-survival Bcl-2 Proteins are Modifiers of MYC-VX-680 Synthetic Lethality
Journal of Cellular Immunology / Sep 23, 2020
Pro-survival Bcl-2 Proteins are Modifiers of MYC-VX-680 Synthetic Lethality. (2020). Journal of Cellular Immunology, 2(5). https://doi.org/10.33696/immunology.2.047
Emerging Strategies to Attack Polyploid Cancer Cells
Journal of Cancer Immunology / Dec 31, 2020
Emerging Strategies to Attack Polyploid Cancer Cells. (2020). Journal of Cancer Immunology, 2(4). https://doi.org/10.33696/cancerimmunol.2.031
Comparison of the Glucocorticoid Receptor Binding and Agonist Activities of Typical Glucocorticoids: Insights into Their Endocrine Disrupting Effects
Chemistry & Biodiversity / Jan 10, 2024
Liang, Y., Li, Z., Zhang, J., Li, T., & Lv, C. (2024). Comparison of the Glucocorticoid Receptor Binding and Agonist Activities of Typical Glucocorticoids: Insights into Their Endocrine Disrupting Effects. Chemistry & Biodiversity, 21(2). Portico. https://doi.org/10.1002/cbdv.202301525
Abstract LB_C10: An orally available small molecule inhibitor for synthetic lethal targeting of MYC expressing tumors
Molecular Cancer Therapeutics / Dec 01, 2023
Shi, Q., Zhang, T., Kalashova, J., Li, J., Yang, C., Li, H., Zhou, X., Long, Y., Abuliezi, Y. X., Lv, G., Yu, D., Zhang, S., Zhang, J., Allen, T. D., Liu, H., & Yang, D. (2023). Abstract LB_C10: An orally available small molecule inhibitor for synthetic lethal targeting of MYC expressing tumors. Molecular Cancer Therapeutics, 22(12_Supplement), LB_C10-LB_C10. https://doi.org/10.1158/1535-7163.targ-23-lb_c10
Abstract C098: Preclinical evaluation of eribulin in a veterinary clinical trial of metastatic spontaneous hemangiosarcoma in pet dogs
Molecular Cancer Therapeutics / Dec 01, 2019
Lopes, C. K., Post, G., Lambert, L., Lewis, B., Allen, T. D., Patel, A., & Littlefield, B. A. (2019). Abstract C098: Preclinical evaluation of eribulin in a veterinary clinical trial of metastatic spontaneous hemangiosarcoma in pet dogs. Molecular Cancer Therapeutics, 18(12_Supplement), C098–C098. https://doi.org/10.1158/1535-7163.targ-19-c098
Abstract 5220: Reciprocal regulation of MYC and LKB1 modulates cell survival and differentiation in lung cancer
Cancer Research / Oct 01, 2014
Cortez, M. A., Yang, C., Byers, L. A., Diao, L., Allen, T., Giri, U., Wang, J., Welsh, J., & Heymach, J. V. (2014). Abstract 5220: Reciprocal regulation of MYC and LKB1 modulates cell survival and differentiation in lung cancer. Cancer Research, 74(19_Supplement), 5220–5220. https://doi.org/10.1158/1538-7445.am2014-5220
Abstract 1149: The role of the novel Notch1-Sox9 signaling axis in NSCLC progression and EMT
Cancer Research / Oct 01, 2014
Capaccione, K. M., Hong, X., Morgan, K. M., Allen, T. D., Miles, G. D., Markert, E. K., Bishop, J. M., & Pine, S. R. (2014). Abstract 1149: The role of the novel Notch1-Sox9 signaling axis in NSCLC progression and EMT. Cancer Research, 74(19_Supplement), 1149–1149. https://doi.org/10.1158/1538-7445.am2014-1149
Abstract B17: Sox9 mediates Notch pathway-induced epithelial-mesenchymal transition (EMT) in lung adenocarcinoma.
Clinical Cancer Research / Jan 15, 2014
Capaccione, K., Hong, X., Morgan, K. M., Liu, W., Allen, T., Bishop, J. M., & Pine, S. R. (2014). Abstract B17: Sox9 mediates Notch pathway-induced epithelial-mesenchymal transition (EMT) in lung adenocarcinoma. Clinical Cancer Research, 20(2_Supplement), B17–B17. https://doi.org/10.1158/1078-0432.14aacriaslc-b17
Data from Interaction between <i>MYC</i> and <i>MCL1</i> in the Genesis and Outcome of Non–Small-Cell Lung Cancer
Mar 30, 2023
Allen, T. D., Zhu, C. Q., Jones, K. D., Yanagawa, N., Tsao, M.-S., & Bishop, J. M. (2023). Data from Interaction between <i>MYC</i> and <i>MCL1</i> in the Genesis and Outcome of Non–Small-Cell Lung Cancer. https://doi.org/10.1158/0008-5472.c.6503157.v1
Multiple negative elements contribute to repression of the HOX11 proto-oncogene
Oncogene / Oct 08, 1998
Brake, R. L., Kees, U. R., & Watt, P. M. (1998). Multiple negative elements contribute to repression of the HOX11 proto-oncogene. Oncogene, 17(14), 1787–1795. https://doi.org/10.1038/sj.onc.1202078
Exploiting mechanism-informed phenotypic screening for development of next-generation antimitotic phytochemicals
Integrative Cancer Science and Therapeutics / Jan 01, 2021
Choudhry, N., David Allen, T., Ahire, V., Zhang, J., & Yang, D. (2021). Exploiting mechanism-informed phenotypic screening for development of next-generation antimitotic phytochemicals. Integrative Cancer Science and Therapeutics, 8(1). https://doi.org/10.15761/icst.1000350
The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells
PLOS ONE / Oct 30, 2023
Kalashova, J., Yang, C., Li, H., Long, Y., Yu, D., Zhang, T., Liu, X., Choudhry, N., Shi, Q., & Allen, T. D. (2023). The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells. PLOS ONE, 18(10), e0293283. https://doi.org/10.1371/journal.pone.0293283
2-Phenoxy-3, 4′-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization
European Journal of Medicinal Chemistry / Jan 01, 2023
Lv, G., Shi, Q., Zhang, T., Li, J., Kalashova, J., Long, Y., Sun, Y., Li, C., Choudhry, N., Li, H., Yang, C., Zhou, X., Reddy, M. C., Anantoju, K. K., Jupelli, R., Zhang, S., Zhang, J., Allen, T., Liu, H., … Yang, D. (2023). 2-Phenoxy-3, 4′-bipyridine derivatives inhibit AURKB-dependent mitotic processes by disrupting its localization. European Journal of Medicinal Chemistry, 245, 114904. https://doi.org/10.1016/j.ejmech.2022.114904
An orally bioavailable 4-phenoxy-quinoline compound as a potent AURKB relocation blocker for cancer treatment
Jan 30, 2023
Li, J., Zhang, T., Shi, Q., Lv, G., Zhou, X., Choudhry, N., Kalashova, J., Yang, C., Li, H., Long, Y., Sakthivel, B., Nimishetti, N., Liu, H., Allen, T. D., Zhang, J., & Yang, D. (2023). An orally bioavailable 4-phenoxy-quinoline compound as a potent AURKB relocation blocker for cancer treatment. https://doi.org/10.1101/2023.01.29.526078
Characterization of mitotic phenotypes associated with a MYC synthetic lethal compound
Apr 05, 2023
Shi, Q., Liu, X., Kalashova, J., Yang, C., Li, H., Long, Y., Zhang, T., Zhang, S., Lv, G., Huang, J., Liu, H., Zhang, J., Allen, T. D., & Yang, D. (2023). Characterization of mitotic phenotypes associated with a MYC synthetic lethal compound. https://doi.org/10.1101/2023.04.03.535438
In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis
Journal of Pharmaceutical and Biomedical Analysis / Aug 01, 2023
Li, J., Choudhry, N., Lv, G., Nimishetti, N., Reddy, M. C., Liu, H., Allen, T. D., Zhang, J., & Yang, D. (2023). In-vitro metabolism of LXY18, an orally available, potent blocker of AURKB relocation in mitosis. Journal of Pharmaceutical and Biomedical Analysis, 232, 115415. https://doi.org/10.1016/j.jpba.2023.115415
Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
Bioorganic & Medicinal Chemistry / Feb 01, 2023
Lv, G., Shi, Q., Zhang, T., Li, J., Long, Y., Zhang, W., Choudhry, N., Yang, K., Li, H., Kalashova, J., Yang, C., Zhou, X., Reddy, M. C., Anantoju, K. K., Zhang, S., Zhang, J., Allen, T. D., Liu, H., Nimishetti, N., & Yang, D. (2023). Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B. Bioorganic & Medicinal Chemistry, 80, 117173. https://doi.org/10.1016/j.bmc.2023.117173
Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment
ACS Pharmacology & Translational Science / Jul 21, 2023
Li, J., Zhang, T., Shi, Q., Lv, G., Zhou, X., Choudhry, N., Kalashova, J., Yang, C., Li, H., Long, Y., Sakthivel, B., Nimishetti, N., Liu, H., Allen, T. D., Zhang, J., & Yang, D. (2023). Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment. ACS Pharmacology & Translational Science, 6(8), 1155–1163. https://doi.org/10.1021/acsptsci.3c00054
The phytochemical, corynoline, diminishes Aurora kinase B activity to induce mitotic defect and polyploidy
Biomedicine & Pharmacotherapy / Mar 01, 2022
Yan, Z., Shi, Q., Liu, X., Li, J., Ahire, V., Zhang, S., Zhang, J., Yang, D., & Allen, T. D. (2022). The phytochemical, corynoline, diminishes Aurora kinase B activity to induce mitotic defect and polyploidy. Biomedicine & Pharmacotherapy, 147, 112645. https://doi.org/10.1016/j.biopha.2022.112645
A high-content screen for anti-mitosis and polyploidy-induction identifies an unknown activity of two benzophenanthridine alkaloids from Corydalis longicalcarata
Phytochemistry Letters / Feb 01, 2021
Li, J., Yan, Z., Li, H., Shi, Q., Huang, L., Nimishetti, N., Allen, T. D., Yang, D., & Zhang, J. (2021). A high-content screen for anti-mitosis and polyploidy-induction identifies an unknown activity of two benzophenanthridine alkaloids from Corydalis longicalcarata. Phytochemistry Letters, 41, 180–185. https://doi.org/10.1016/j.phytol.2020.12.001
A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil
PLOS ONE / Mar 24, 2021
Zhang, J., Zhang, S., Shi, Q., Allen, T. D., You, F., & Yang, D. (2021). A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil. PLOS ONE, 16(3), e0248355. https://doi.org/10.1371/journal.pone.0248355
The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects
Journal of Natural Products / Aug 18, 2021
Li, J., Yan, Z., Li, H., Shi, Q., Ahire, V., Zhang, S., Nimishetti, N., Yang, D., Allen, T. D., & Zhang, J. (2021). The Phytochemical Scoulerine Inhibits Aurora Kinase Activity to Induce Mitotic and Cytokinetic Defects. Journal of Natural Products, 84(8), 2312–2320. https://doi.org/10.1021/acs.jnatprod.1c00429
Notch1 activates angiogenic regulator Netrin4 in endothelial cells
Journal of Cellular and Molecular Medicine / Feb 19, 2019
Liu, Q., Allen, T. D., Song, W., Wada, Y., Lobe, C. G., & Liu, J. (2019). Notch1 activates angiogenic regulator Netrin4 in endothelial cells. Journal of Cellular and Molecular Medicine, 23(5), 3762–3766. Portico. https://doi.org/10.1111/jcmm.14240
A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil
Oct 10, 2019
Zhang, J., Zhang, S., Shi, Q., Allen, T. D., You, F., & Yang, D. (2019). A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil. https://doi.org/10.1101/801134
Purification, identification, and characterization of two benzophenanthridine alkaloids fromCorydalis longicalcaratarhizomes with anti-mitotic and polyploidy-inducing activities
Oct 31, 2019
Li, J., Yan, Z., Li, H., Shi, Q., Huang, L., Allen, T. D., Yang, D., & Zhang, J. (2019). Purification, identification, and characterization of two benzophenanthridine alkaloids fromCorydalis longicalcaratarhizomes with anti-mitotic and polyploidy-inducing activities. https://doi.org/10.1101/821124
The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin1/Atg6-mediated lethal autophagy in polyploid cells
Jun 27, 2019
Zhang, J., Zhang, S., Wu, F., Shi, Q., Allen, T., You, F., & Yang, D. (2019). The anti-apoptotic proteins Bcl-2 and Bcl-xL suppress Beclin1/Atg6-mediated lethal autophagy in polyploid cells. https://doi.org/10.1101/684266
Dihydroartemisinin up‐regulates
VE ‐cadherin expression in human
renal glomerular endothelial cells
Journal of Cellular and Molecular Medicine / Nov 29, 2017
Li, L., Chen, X., Dong, F., Liu, Q., Zhang, C., Xu, D., Allen, T. D., & Liu, J. (2017). Dihydroartemisinin up‐regulates <scp>VE</scp>‐cadherin expression in human renal glomerular endothelial cells. Journal of Cellular and Molecular Medicine, 22(3), 2028–2032. Portico. https://doi.org/10.1111/jcmm.13448
Glomerular endothelial cell IQGAP2 and filtration barrier function
Kidney International / May 01, 2016
Dong, F., Li, L., Chen, X., Allen, T., & Liu, J. (2016). Glomerular endothelial cell IQGAP2 and filtration barrier function. Kidney International, 89(5), 1160–1161. https://doi.org/10.1016/j.kint.2015.09.006
CD 109 is specifically expressed
in endothelial cells of cutaneous
cavernous haemangioma
Histopathology / Jan 15, 2015
Dong, F., Cheng, Y., Sun, Q., Lu, W., Zhang, G., Li, L., Allen, T. D., & Liu, J. (2015). <scp>CD</scp>109 is specifically expressed in endothelial cells of cutaneous cavernous haemangioma. Histopathology, 67(1), 133–135. Portico. https://doi.org/10.1111/his.12609
Postnatal Notch1 activation induces T-cell malignancy in conditional and inducible mouse models
International Journal of Oncology / Aug 29, 2014
LIU, J., DONG, F., FUNG, I., CHEN, E., ALLEN, T. D., DEUTSCH, U., & LOBE, C. G. (2014). Postnatal Notch1 activation induces T-cell malignancy in conditional and inducible mouse models. International Journal of Oncology, 45(5), 1997–2004. https://doi.org/10.3892/ijo.2014.2626
Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse
Antiviral Research / Aug 01, 1997
Bolger, G. T., Allen, T., Garneau, M., Lapeyre, N., Liard, F., & Jaramillo, J. (1997). Cutaneously applied acyclovir acts systemically in the treatment of herpetic infection in the hairless mouse. Antiviral Research, 35(3), 157–165. https://doi.org/10.1016/s0166-3542(97)00024-7
Education
University of Toronto
PhD, Department of Medical Biophysics - Molecular and Cellular Biology of Cancer / April, 2004
University of Toronto
MSc, Department of Medical Biophysics - Molecular and Cellular Biology of Cancer / October, 1998
BSc, Biology/Pharmacology Co-op Program / May, 1995
Experience
The One Health Company
Scientific Writing Consultant / February, 2024 — Present
Science-based writing projects - The One Health Company offers next-generation sequencing screening of the canine cancer genome, coupled with matching targeted therapeutics.
Oncology Lead / August, 2018 — February, 2020
Product development, science consulting and writing projects related to PR, publications, legal and regulatory.
Tradewind BioScience, Inc.
CEO / January, 2018 — June, 2023
Startup that built an antibody for ovarian cancer treatment.
Anticancer Bioscience, Ltd.
VP Translational Biology and Business Development / August, 2018 — October, 2023
Hybrid position - responsible for both the mentoring of scientific teams researching small molecule drugs (MOA, PK, in vivo, etc.) and worked on strategic business development projects. Notably, the outward face of the company for partnering, vendor interactions and as a legal liaison.
Links & Social Media
Join Thaddeus on NotedSource!
Join Now
At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.
For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.
For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.